Carroll Financial Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $962K | Buy |
1,454
+30
| +2% | +$18.7K | 0.05% | 185 |
|
|
2021
Q3 | $813K | Buy |
1,424
+23
| +2% | +$12.6K | 0.05% | 205 |
|
|
2021
Q2 | $706K | Buy |
1,401
+76
| +6% | +$35.9K | 0.04% | 214 |
|
|
2021
Q1 | $604K | Sell |
1,325
-145
| -10% | -$69.2K | 0.04% | 229 |
|
|
2020
Q4 | $684K | Buy |
1,470
+39
| +3% | +$18.3K | 0.05% | 200 |
|
|
2020
Q3 | $631K | Sell |
1,431
-2
| -0.1% | -$826 | 0.05% | 194 |
|
|
2020
Q2 | $519K | Buy |
1,433
+73
| +5% | +$24.5K | 0.04% | 213 |
|
|
2020
Q1 | $385K | Buy |
1,360
+2
| +0.1% | +$631 | 0.04% | 224 |
|
|
2019
Q4 | $441K | Sell |
1,358
-2
| -0.1% | -$606 | 0.04% | 235 |
|
|
2019
Q3 | $396K | Sell |
1,360
-7
| -0.5% | -$2K | 0.03% | 244 |
|
|
2019
Q2 | $401K | Buy |
1,367
+118
| +9% | +$32.5K | 0.03% | 243 |
|
|
2019
Q1 | $341K | Sell |
1,249
-23
| -2% | -$5.72K | 0.03% | 239 |
|
|
2018
Q4 | $285K | Hold |
1,272
| – | – | 0.03% | 226 |
|
|
2018
Q3 | $310K | Sell |
1,272
-18
| -1% | -$4.14K | 0.03% | 226 |
|
|
2018
Q2 | $267K | Buy |
1,290
+120
| +10% | +$25.5K | 0.03% | 240 |
|
|
2018
Q1 | $241K | Buy |
1,170
+25
| +2% | +$5.25K | 0.03% | 254 |
|
|
2017
Q4 | $217K | Buy |
1,145
+125
| +12% | +$23.9K | 0.02% | 261 |
|
|
2017
Q3 | $197K | Hold |
1,020
| – | – | 0.02% | 268 |
|
|
2017
Q2 | $177K | Hold |
1,020
| – | – | 0.02% | 284 |
|
|
2017
Q1 | $156K | Hold |
1,020
| – | – | 0.02% | 289 |
|
|
2016
Q4 | $143K | Sell |
1,020
-56
| -5% | -$8.26K | 0.02% | 290 |
|
|
2016
Q3 | $171K | Hold |
1,076
| – | – | 0.03% | 257 |
|
|
2016
Q2 | $158K | Hold |
1,076
| – | – | 0.03% | 263 |
|
|
2016
Q1 | $152K | Buy |
1,076
+200
| +23% | +$26.8K | 0.03% | 256 |
|
|
2015
Q4 | $124K | Buy |
876
+300
| +52% | +$40K | 0.03% | 264 |
|
|
2015
Q3 | $73K | Hold |
576
| – | – | 0.02% | 327 |
|
|
2015
Q2 | $75K | Buy |
+576
| New | +$75.1K | 0.02% | 310 |
|
|
2015
Q1 | – | Sell |
-150
| Closed | -$19K | – | 862 |
|
|
2014
Q4 | $19K | Sell |
150
-520
| -78% | -$63.2K | 0.01% | 401 |
|
|
2014
Q3 | $79K | Hold |
670
| – | – | 0.02% | 249 |
|
|
2014
Q2 | $79K | Hold |
670
| – | – | 0.02% | 255 |
|
|
2014
Q1 | $81K | Buy |
670
+150
| +29% | +$17.8K | 0.03% | 240 |
|
|
2013
Q4 | $57K | Hold |
520
| – | – | 0.02% | 259 |
|
|
2013
Q3 | $47K | Hold |
520
| – | – | 0.02% | 296 |
|
|
2013
Q2 | $44K | Buy |
+520
| New | +$43.3K | 0.02% | 247 |
|
Other funds holding TMO
Carroll Financial Associates's TMO Position: Q4 2021 in Review
Carroll Financial Associates increased its Thermo Fisher Scientific (TMO) stake by 2.1% in Q4 2021, buying an estimated $18.7K and bringing the position to 1,454 shares worth $962K. The position accounts for 0.05% of the portfolio, ranked #185.
Carroll Financial Associates first reported a position in TMO in Q2 2013 and has held it in 34 quarters since. 2,342 funds tracked by Wall St. Rank hold TMO as of Q4 2021.
- Carroll Financial Associates held 1,454 shares of Thermo Fisher Scientific worth $962K as of Q4 2021.
- Carroll Financial Associates bought 30 Thermo Fisher Scientific shares in Q4 2021, an estimated $18.7K.
- Thermo Fisher Scientific made up 0.05% of Carroll Financial Associates's portfolio in Q4 2021, its #185 holding.
- Carroll Financial Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 34 quarters since.
- 2,342 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.